A breast cancer diagnosis during pregnancy requires a shared decision between cancer and maternity teams. It does not mean every investigation or treatment must wait until after birth. Equally, a standard plan for someone who is not pregnant cannot simply be copied: gestational age, cancer stage, tumour features and treatment urgency matter. An overseas consultation should support that discussion rather than delay it.
Normal pregnancy changes can make a breast abnormality easier to attribute to hormones or preparation for feeding. A new or persistent unusual change nevertheless needs clinical assessment. The NCI information on breast cancer during pregnancy describes ultrasound as a usual first investigation for a suspicious area, with other imaging and biopsy when indicated. The chosen investigations take the pregnancy into account.
Do not independently cancel recommended diagnostic work because the word “test” sounds risky. Ordering a large overseas screening package without agreement is not the answer either. Each investigation should address a particular clinical question and have an explanation of its benefits and risks in the actual circumstances.
The discussion usually involves an oncologist, a breast surgeon and maternity specialists familiar with high-risk pregnancy, with other expertise added as needed. The important point is a common plan rather than a long list of specialties. An operation date or systemic-treatment phase should fit with the obstetric assessment, not be scheduled independently by two departments.
Ask which clinician is responsible for coordinating medical decisions. An interpreter or travel coordinator can help information move between teams, but cannot decide whether a medicine is appropriate or when delivery should happen. The written cancer sequence and maternity monitoring plan should agree.
Some treatments can be given during pregnancy, while others need different timing or alternatives. NCI describes surgery and selected chemotherapy after the first trimester as possibilities. Radiotherapy is generally postponed until after birth, and endocrine treatment, many targeted treatments and immunotherapy have restrictions. These are broad distinctions, not permission to choose a medicine or change a schedule yourself.
The discussion needs to address two questions clearly: the risk to the mother of delaying cancer treatment, and the pregnancy-related risks of the proposed approach. Neither belongs outside the conversation. A blanket statement that everything is safe does not replace assessment of the actual regimen. Decisions about continuing a pregnancy are individual and must include the patient’s choices, without pressure from a travel organiser.
Provide the current gestational age, expected delivery date, pregnancy history and prescriptions alongside complete pathology, tumour receptor results and existing imaging. If cancer treatment has begun, include actual administration dates and medicine names. A pregnancy week copied from an old report must not be mistaken for the gestational age at the new appointment.
When translating, preserve exact medicine names and distinguish treatments proposed from treatments already given. A brief timeline helps both teams understand when the finding appeared, when the diagnosis was established and which decision is now urgent. Include the contact details of the clinicians who can resolve missing information.
Confirm that the receiving centre can provide the necessary cancer and maternity care together, and establish how it will communicate with the team at home. Fitness to fly, time needed near the hospital and arrangements for an urgent problem require clinical assessment. The diagnosis alone cannot justify promising a short, uncomplicated trip.
For an oncology second opinion, frame the request as coordination of two treatment priorities rather than a search for a treatment advertised as harmless. After delivery, breastfeeding and medication compatibility need a separate discussion; they are not determined by a generic travel leaflet. If health deteriorates, obtain local medical help promptly rather than waiting for an international reply.
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.